Applied NeuroSolutions biomarker may predict Alzheimer's disease progression
Wed, 25 May 2005 06:00 PM EST
... A biomarker pioneered by Applied NeuroSolutions (OTC BB: APNS, and exclusively utilized in its Alzheimer's diagnostic assay, shows great promise in predicting brain atrophy in patients with Alzheimer's disease, according to a group of researchers in the US, Canada, and Europe led by Dr... click link for more info. ...
Related Topics
- Alzheimer's Disease
- Applied kinesiology
- Alzheimer's Caregivers
- Alzheimer disease
- Progression to stupor or coma
- Diseases & Conditions
- Heart Disease
- Bone Disease
- Lung Diseases & Disorders
- Huntington's Disease
- Kidney Disease
- Rare Diseases
- Crohn's Disease
- Graves' Disease
- Autoimmune Diseases
- Periodontal Disease
- Cardiovascular Diseases And Disorders
- Liver Disease
- Vascular Disease
- Coronary Artery Disease

Not Signed In -

